Authors: Aghel, N.Aff1, IDs41409023019282_cor1, Lui, M., Wang, V., Khalaf, D., Mian, H., Hillis, C., Walker, I., Leber, B., Lipton, J. H., Aljama, M., Lepic, K., Berg, T., Garcia-Horton, A., Petropoulos, J., Masoom, H., Leong, D. P.
Superior Title: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 58(5):478-490
Authors: Aghel N, Delgado DH, Lipton JH
Superior Title: Vascular Health and Risk Management, Vol Volume 13, Pp 293-303 (2017)
Subject Terms: BCR-ABL, Tyrosine kinase inhibitor, peripheral arterial disease, cardiovascular disease, adverse event, Diseases of the circulatory (Cardiovascular) system, RC666-701
File Description: electronic resource
Relation: https://www.dovepress.com/cardiovascular-toxicities-of-bcr-abl-tyrosine-kinase-inhibitors-in-chr-peer-reviewed-article-VHRM; https://doaj.org/toc/1178-2048
Authors: Liu, S., Nolan, M., Aghel, N., Belford, L., Silversides, C., Hines, M., Thompson, K., Amir, E., Maxwell, C., Thavendiranathan, P.
Superior Title: Canadian Journal of Cardiology ; volume 34, issue 10, page S35 ; ISSN 0828-282X
Subject Terms: Cardiology and Cardiovascular Medicine
Authors: Aghel, N, Lui, M, Mian, H, Khalaf, D, Hillis, C, Petropoulos, J, Wang, V, Leber, B, Lipton, J, Walker, I, Leong, D
Superior Title: European Heart Journal ; volume 42, issue Supplement_1 ; ISSN 0195-668X 1522-9645
Subject Terms: Cardiology and Cardiovascular Medicine
Authors: Aghel, N
Superior Title: Talanta ; volume 62, issue 2, page 407-411 ; ISSN 0039-9140
Subject Terms: Analytical Chemistry
Availability:
https://doi.org/10.1016/j.talanta.2003.08.011
https://api.elsevier.com/content/article/PII:S0039-9140(03)00458-2?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0039-9140(03)00458-2?httpAccept=text/plain
Authors: Arzi, A., Sarkaki, A., Najad, S. Saeed, Nazari, Z., Aghel, N.
Superior Title: In Toxicology Letters 28 August 2011 205 Supplement:S83-S84